SCHEMBL6140132

SCHEMBL6140132

CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3[C@@H](F)C[C@@]21C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 7/20 0.50
▸ NR3C1 P04150 5/20 0.48
▸ LMNA P02545 4/20 0.48
▸ CYP3A4 P08684 4/20 0.48
▸ SLC6A4 P31645 4/20 0.48
▸ ABCB11 O95342 3/20 0.48
▸ CYP2C19 P33261 3/20 0.48
▸ ESR1 P03372 3/20 0.48
▸ SHBG P04278 2/20 0.48
▸ TSHR P16473 1/20 0.48
▸ HIF1A Q16665 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ ADRA2A P08913 1/20 0.48
▸ AR P10275 4/20 0.47
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ CHRM2 P08172 1/20 0.45
▸ ACHE P22303 1/20 0.45
▸ SLC6A2 P23975 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Norethandrolone SCHEMBL147638 0.81 LMNA (0.71) PGRNR3C1LMNACYP3A4SLC6A4
Norethandrolone SCHEMBL23801611 0.81 LMNA (0.71) PGRNR3C1LMNACYP3A4SLC6A4
SCHEMBL4587006 0.77 MAPT (0.55) PGRNR3C1LMNACYP3A4ABCB11
SCHEMBL11793678 0.76 PGR (0.61) PGRNR3C1LMNACYP3A4SLC6A4
SCHEMBL11794466 0.76 PGR (0.61) PGRNR3C1LMNACYP3A4SLC6A4
SCHEMBL9811566 0.75 PGR (0.52) PGRNR3C1LMNACYP3A4SLC6A4
SCHEMBL5501842 0.75 SERPINA6 (0.64) PGRNR3C1LMNACYP3A4ESR1
SCHEMBL908750 0.74 CYP19A1 (0.64) PGRLMNASHBGTSHRALDH1A1
SCHEMBL12902157 0.74 CYP19A1 (0.64) PGRLMNASHBGTSHRALDH1A1
Norethandrolone SCHEMBL13724392 0.74 SHBG (0.75) PGRNR3C1LMNACYP3A4SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050075322-A1 Androgenic 7-substituted 11-halogen steroids BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2005-04-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075322-A1 Androgenic 7-substituted 11-halogen steroids NR5A1, HSD17B11, HSD11B1 PGR 174/4885NR3C1 31/4885LMNA 2482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback